Emerging Fields
We are expanding our therapeutic innovations by investing in multiple therapeutic modalities like therapeutic peptides, proteins, antibodies and gene therapy. This forward-thinking approach aims to develop the next generation of treatment.
Neuroimmunology
The immune system is now recognized as a key player in the pathophysiology of multiple neurological disorders. Neuroimmunology explores the intricate and bidirectional interactions between the central nervous system (CNS) and the immune system, potentially uncovering the inflammatory processes that drive neurological disease and providing an opportunity for innovative therapies. At Neurocrine, we view neuroimmunology as an important element of the future of neuroscience.
Gene Therapy
Gene therapy holds the promise of going beyond treating the symptoms of a disorder. This therapeutic approach can be used to address the causes of genetic diseases, offering the potential to slow, halt, or even reverse the course of such diseases. At Neurocrine Biosciences, our Research teams are developing novel gene therapy approaches to tackle some of the most intractable diseases of the brain, such as rare and severe genetic forms of neurological/neurodegenerative diseases.
